This monograph, published in Vaccine, summarizes the present state of human papillomavirus vaccines and screening in the prevention of cervical cancer. It provides a number of articles covering epidemiological achievements, technical developments, …

This article, published in the Journal of Experimental Medicine, discusses a study in the United States that suggests that natural immunity to meningococcal disease is initiated, reinforced, and broadened by intermittent carriage of different …

This article, published in the Journal of Experimental Medicine, reviews an earlier study of the age-specific incidence of meningococcal meningitis in the United States that found that the proportion of individuals with serum bactericidal …

Cervical cancer, which is caused by human papillomavirus (HPV), is estimated to have been responsible for almost 260,000 deaths in 2005. Eighty percent of these deaths occurred in developing countries. Fortunately, in 2006 a vaccine that protects …

This article, published in the Weekly Epidemiological Record, is the first World Health Organization (WHO) position paper on vaccines against diseases caused by human papillomaviruses (HPV). It provides essential background information on HPV and …

Currently, no explanation exists for the epidemic pattern of meningitis in the African meningitis belt, in spite of recent progress in disease surveillance. Such a model would be conducive to mathematically mapping vaccine strategies or predicting …

This web page provides up-to-date information on regional and global incidence of vaccine-preventable diseases, as well as rates of immunization coverage. Most of the data is derived from official reports by World Health Organization (WHO) Member …

The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1 to 29-year-olds in Burkina Faso in 2010. The authors of this article, published in Clinical Infectious …

This poster, presented at the 2008 International Pathogenic Neisseria Conference, displays the results of a study to determine the effectiveness of the Standard Operating Procedures that were developed in 2001 to 2002 to codify and enhance …

This report summarizes the results of a six-month inquiry by the UK All-Party Parliamentary Group for Pneumococcal Disease Prevention in the Developing World (APPG) on the global disease burden of pneumococcal disease and pneumonia, …

In this study, published in PLoS Medicine, researchers aimed to establish base-line estimates of disease incidence in resource poor settings and provide accurate information to assist in determining the need for vaccine prevention.

This article, published in AIDS, describes a cohort surveillance study conducted in South Africa to compare the incidence of meningococcal disease among HIV-infected individuals versus uninfected individuals. The authors also evaluated the extent to …

This commentary, published in the journal Science, discusses one of the worst meningococcal meningitis epidemics in years in Nigeria and Niger. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal …

This article, published in the World Health Organization's Weekly Epidemiological Record, summarizes an intercountry meeting on enhanced surveillance and responses to meningitis epidemics held in October 2006 in Bamako, Mali. More than 80 …

Introducing rotavirus vaccines, in conjuction with establishing improved hygiene and water purification, represents of the best hope for reducing mortality among children under five years of age in areas where diarrheal disease is a serious burden. …

This article, published in BMC Public Health, describes a discrete event simulation of the epidemiology of invasive meningococcal disease to quantify the potential impact of implementing routine vaccination of adolescents in the United States with a …

This fact sheet summarizes efforts to develop and apply standardized surveillance methods to estimate the burden of JE disease in endemic regions. Reliable disease burden data will help policymakers as they consider JE vaccine introduction to …

This strategic plan, prepared by PATH from the contributions of 17 partner organizations, provides details on priority activities that must be sustained for continued momentum in Japanese encephalitis (JE) control, including improved …

PATH launched this web portal to help countries track data about JE disease, record outbreaks, and exchange information on control strategies. The network is coordinated through technical support from Voxiva in New Delhi, India.

An update on surveillance activities in Cambodia supported by PATH's JE Project.

An update on surveillance activities in Indonesian districts supported by PATH's JE Project.

This document is an excerpt from the World Health Organization-recommended standards for surveillance of selected vaccine-preventable diseases, including Japanese encephalitis.

To investigate the potential herd immunity effect of MenAfriVac™, a new conjugate vaccine against serogroup A Neisseria meningitidis, the authors of this article, published in Transactions of the Royal Society of Tropical …

This article, published in Clinical Microbiology and Infection, summarizes a meeting organized by PATH and Fondation Mérieux from October 18 to 20, 2009 in Les Pensiéres, France, during which participants evaluated current pneumococcal …

This article, published in FEMS Microbiology Reviews, reviews previous meningococcal carriage studies in European countries in order to learn more about the disease and the potential impact of mass vaccination with meningococcal vaccines. The …